Cameo Resources Inc. (CSE:MEO)
Canada flag Canada · Delayed Price · Currency is CAD
0.1100
0.00 (0.00%)
Aug 7, 2025, 1:32 PM EDT

Theseus Pharmaceuticals Income Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20182020
Period Ending
May '25 Aug '24 Aug '23 Aug '22 Aug '21 Aug '18 2020
Selling, General & Admin
0.30.250.250.140.130.06
Upgrade
Operating Expenses
0.320.30.290.140.110.06
Upgrade
Operating Income
-0.32-0.3-0.29-0.14-0.11-0.06
Upgrade
Other Non Operating Income (Expenses)
0.02----0.01-
Upgrade
EBT Excluding Unusual Items
-0.19-0.3-0.29-0.14-0.12-0.06
Upgrade
Gain (Loss) on Sale of Investments
-0-00-0.010-
Upgrade
Other Unusual Items
-0.010.260.01---
Upgrade
Pretax Income
-0.2-0.04-0.27-0.15-0.12-0.06
Upgrade
Net Income
-0.2-0.04-0.27-0.15-0.12-0.06
Upgrade
Net Income to Common
-0.2-0.04-0.27-0.15-0.12-0.06
Upgrade
Shares Outstanding (Basic)
29231717175
Upgrade
Shares Outstanding (Diluted)
29231717175
Upgrade
Shares Change (YoY)
44.53%35.67%--234.12%-
Upgrade
EPS (Basic)
-0.01-0.00-0.02-0.01-0.01-0.01
Upgrade
EPS (Diluted)
-0.01-0.00-0.02-0.01-0.01-0.01
Upgrade
Free Cash Flow
-0.5-0.64-0.19-0.02-0.01-
Upgrade
Free Cash Flow Per Share
-0.02-0.03-0.01-0.00-0.00-
Upgrade
EBITDA
-----0.02
Upgrade
D&A For EBITDA
-----0.09
Upgrade
EBIT
-0.32-0.3-0.29-0.14-0.11-0.06
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.